Welcome to our dedicated page for Zoetis news (Ticker: ZTS), a resource for investors and traders seeking the latest updates and insights on Zoetis stock.
Zoetis Inc. (ZTS) drives innovation in animal health as the global leader in veterinary pharmaceuticals and diagnostics. This news hub provides investors and industry professionals with essential updates on developments impacting companion animal care and livestock health systems.
Access curated press releases and analysis covering product approvals, research breakthroughs, and financial performance. Our repository includes updates on vaccine innovations, parasiticides, diagnostic tools, and strategic partnerships across 100+ markets. Monitor earnings announcements, manufacturing expansions, and regulatory milestones that shape this $80B sector.
Bookmark this page for streamlined tracking of Zoetis' operational progress in developing solutions for pets and farm animals. Return regularly to stay informed about initiatives affecting animal welfare standards and agricultural productivity worldwide.
The Zoetis Foundation announced its first round of 2023 grants totaling
Zoetis Inc. (NYSE: ZTS) is set to host a webcast and conference call on May 4, 2023, at 8:30 a.m. (ET) to discuss its first quarter 2023 financial results. CEO Kristin Peck and CFO Wetteny Joseph will present the results and answer questions from financial analysts. Interested investors and the public can access the live webcast through the Zoetis website, and a replay will be available following the event. In 2022, Zoetis generated impressive revenue of $8.1 billion and continues to lead in animal health innovation across over 100 countries.
FAQ
What is the current stock price of Zoetis (ZTS)?
What is the market cap of Zoetis (ZTS)?
